GlyCosmos Portal

GlyCOVID

GlyCOVID is a dataset of RDFized COVID-19 data related to glycans. Resources will be added incrementally as publications are curated.

Longitudinal Development of Antibody Responses in COVID-19 Patients of Different Severity with ELISA, Peptide, and Glycan Arrays: An Immunological Case Series.
Heidepriem J, et al.
Pathogens. 2021; 10(4):438. https://doi.org/10.3390/pathogens10040438

A longitudinal analysis of three COVID-19 patients with moderate (#1) and mild disease (#2 and #3) was published. Antibody serum responses were analyzed using spike glycoprotein enzyme linked immunosorbent assay (ELISA), full-proteome peptide, and glycan microarrays. In this Glycovid dataset, the data from these glycan microarray experiments have been RDFized. Fluorescence intensity is given in arbitrary fluorescence units (AFU) as reported in this publication.

Source	Last Updated
PSICQUIC	March 30, 2022

Displaying entries **3251 - 3275** of **4050** in total

« First

‹ Prev

…

127

128

129

130

131

132

133

134

135

…

Next ›

Last »
Antibody	Patient	Onset (days)	Symptom	GlyTouCan ID ▼	Arbitrary Fluorescence Units (AFU)
IgG	Patient 2	15	mild	G16579HJ	47
IgG	Patient 2	24	mild	G16579HJ	45
IgM	Patient 2	15	mild	G16579HJ	274
IgM	Patient 2	24	mild	G16579HJ	297
IgM	Patient 1	6	moderate	G16579HJ	73
IgA	Patient 2	3	mild	G16579HJ	472
IgG	Patient 2	3	mild	G16579HJ	62
IgM	Patient 2	3	mild	G16579HJ	436
IgA	Patient 3	-180	mild	G16579HJ	265
IgA	Patient 3	11	mild	G16579HJ	727
IgG	Patient 3	-180	mild	G16579HJ	58
IgG	Patient 3	11	mild	G16579HJ	148
IgM	Patient 3	-180	mild	G16579HJ	171
IgA	Patient 3	4	mild	G16579HJ	717
IgG	Patient 3	4	mild	G16579HJ	156
IgM	Patient 3	11	mild	G16579HJ	1272
IgM	Patient 3	4	mild	G16579HJ	1433
IgA	Patient 4	12	mild	G16579HJ	663
IgG	Patient 4	12	mild	G16579HJ	134
IgM	Patient 4	12	mild	G16579HJ	612
IgA	Patient 1	10	moderate	G15407YE	560
IgA	Patient 1	22	moderate	G15407YE	565
IgA	Patient 1	6	moderate	G15407YE	624
IgG	Patient 1	10	moderate	G15407YE	103
IgG	Patient 1	22	moderate	G15407YE	99